| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/14/2006 | EP0783321B1 Vr-2332 viral nucleotide sequence and methods of use |
| 06/14/2006 | EP0777687B1 Trefoil peptide dimer |
| 06/14/2006 | EP0760867B1 Compositions and methods relating to dna mismatch repair genes |
| 06/14/2006 | EP0757556B1 Borrelia burgdorferi bacterin |
| 06/14/2006 | EP0750509B2 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 06/14/2006 | EP0723536B2 An aglucone isoflavone enriched vegetable protein whey, and process for producing |
| 06/14/2006 | EP0699236B2 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 06/14/2006 | EP0666868B2 Use of anti-VEGF antibodies for the treatment of cancer |
| 06/14/2006 | DE19941897B4 IL-6 Rezeptor-Protein, Beta-Kette (gp130) des IL-6 Rezeptor-Proteins, für diese Proteine kodierende DNA, davon abgeleitete RNA, Peptid mit den Aminosäuren 771-811 dieser Beta-Kette oder Teilen davon und deren Verwendungen IL-6 receptor protein beta-chain (gp130) of the IL-6 receptor protein, DNA encoding for these proteins, derived RNA, peptide with the amino acids 771-811 of the beta-chain or parts thereof and their uses |
| 06/14/2006 | DE102005016229B3 Dry atomizer, useful for atomizing a medicament preparation, comprises a housing, a gas pipeline with gas inlet, and a gas deflection with gas outlet, which acts as a filter |
| 06/14/2006 | CN1788092A Engineering of leader peptides for the secretion of recombinant proteins in bacteria |
| 06/14/2006 | CN1788088A Mutant vesicular stomatitis viruses and use thereof |
| 06/14/2006 | CN1788084A Crystal structure of human coronavirus 229E main proteinase, and uses thereof for developing SARS inhibitors |
| 06/14/2006 | CN1788078A Plant cells and plant bodies with modified cell growth, development and differentiation |
| 06/14/2006 | CN1788017A Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 06/14/2006 | CN1788016A Purification of peptides from colostrum |
| 06/14/2006 | CN1787840A Drug for treating hemophilia and method of treating hemophilia using the same |
| 06/14/2006 | CN1787832A Method of treating inflammtory disease associated with bone destruction |
| 06/14/2006 | CN1787828A Heterocarpin, a plant-derived protein with anti-cancer properties |
| 06/14/2006 | CN1786174A Human keratin cell growth factor 2 protein expression plasmid carrier |
| 06/14/2006 | CN1786168A Paddy rice tip flower dereloped new gene Dhl and its clone method |
| 06/14/2006 | CN1786165A Preparation method of recombination staphylococcus aureus enterotoxin C2 |
| 06/14/2006 | CN1786031A Glucagon kind polypeptide-1 analogue, its preparation method and application |
| 06/14/2006 | CN1786030A Pig production and immunity related protein, its coding gene and application |
| 06/14/2006 | CN1786029A Plant dehydration response element conjugated protein, its coding gene and application |
| 06/14/2006 | CN1786028A Plant dehydration response element conjugated protein, its coading gone and application |
| 06/14/2006 | CN1786027A Paddy rice anti contravariance related gene-anchor series repetitive protein gene and its application |
| 06/14/2006 | CN1786026A Production technology of fluorescent phycocyanin and crystal and product thereof |
| 06/14/2006 | CN1786025A Production technology of allophycocyanin and crystal and product thereof |
| 06/14/2006 | CN1786024A Production technology of phycoerythrin and crystal and product thereof |
| 06/14/2006 | CN1786023A Lucid ganoderma poly saccharide peptide standard product, sts preparation method and application |
| 06/14/2006 | CN1786022A Mermaid luminous bacillus outer membrane protein V and coding sequence, its preparation method and application |
| 06/14/2006 | CN1786018A Separation and purification of high purity hemoglobin and virus inactivation technology |
| 06/14/2006 | CN1785214A Extractives of pearl nacre mother protein and its application |
| 06/14/2006 | CN1259422C Peptides derived from attachment (G) protein of respiratory syncytial virus |
| 06/14/2006 | CN1259421C Bt-cry1 Ah gene with high toxicity for lepidoptera and its expression product |
| 06/14/2006 | CN1259420C Sea anemone neurotoxin gene Sr3 and application thereof |
| 06/14/2006 | CN1259419C Sea anemone neurotoxin gene Sr2 and application thereof |
| 06/14/2006 | CN1259417C Coding sequence of arisaema agglutinant protein and its application |
| 06/14/2006 | CN1259416C Human DNA polymerase beta mutant gene |
| 06/14/2006 | CN1259338C Separation method for plasma protein |
| 06/14/2006 | CN1259337C Synthesis, expression, preparation and application for human parathyroid hormone gene mutant |
| 06/14/2006 | CN1259336C Method for purifying composite interferon |
| 06/14/2006 | CN1259335C Method for preparing phycocyanin from blue algae in water bloom |
| 06/14/2006 | CN1259334C Method for purifying microcysin |
| 06/14/2006 | CN1259333C Separation purification method for preparing sex-gene recombination spider dragline silk protein |
| 06/13/2006 | US7062219 Using cell-based assays to assess biological activity of chemical compounds and mechanism-of-action of new biological targets; drug screening |
| 06/13/2006 | US7060875 Methods for delaying leaf senescence using the ORE7 gene |
| 06/13/2006 | US7060874 Bioengineering cotton fiber properties |
| 06/13/2006 | US7060872 Method for producing plants having modified canopy size or seedless fruit |
| 06/13/2006 | US7060869 Fluorescent indicator for use as tool in genetic engineerging |
| 06/13/2006 | US7060868 Autoimmune disease model animal |
| 06/13/2006 | US7060805 Methods for isolating tissue factor inhibitor |
| 06/13/2006 | US7060804 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses |
| 06/13/2006 | US7060803 Metal complex-protein composite and hydrogenation catalyst |
| 06/13/2006 | US7060801 Antibodies to human growth factor huXAG-3 and methods of use |
| 06/13/2006 | US7060800 Polypeptides for use in the treatment and diagnosis of crohn's disease |
| 06/13/2006 | US7060797 Using isolated polypeptide, polynucleotide; antibodies, epitopes that bind to these |
| 06/13/2006 | US7060795 Comprises nucleotide sequences coding matrix metalloprotease enzyme inhibitors for use in the treatment of injuries; wound healing agents |
| 06/13/2006 | US7060794 Nucleotide sequences coding polypeptide for use in the treatment of arrhythmias, hypertension, angina, asthma, diabetes, kidney deffects, urinary, cerebral and autoimmune diseases |
| 06/13/2006 | US7060793 Circularly permuted fluorescent protein indicators |
| 06/13/2006 | US7060791 Genetic engineering; bone disorders; anticancer agent |
| 06/13/2006 | US7060790 Genetic engineering; antitumor agents; therapy for microbiocide infections; antiinflammatory agents; immunology |
| 06/13/2006 | US7060789 Ricin-like toxins for treatment of cancer |
| 06/13/2006 | US7060688 A gene therapy for cancers, comprising a cancer suppressing gene; genetic engineering, duplicated gene, cloned gene |
| 06/13/2006 | US7060682 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes |
| 06/13/2006 | US7060680 Compositions for maintaining the integrity of the gastrointestinal tract luminal lining in a mammal, including (1) limiting epithelial cell proliferation, (2) inhibiting ulcerative lesion formation, (3) inhibiting inflammation |
| 06/13/2006 | US7060679 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 06/13/2006 | US7060678 peptidomimetic analogs of VIP receptor binding inhibitors replacing the di-/tri-peptides having proline as one of the amino acids, or proline alone, with at leat one unit from enantiomorphic 4-(aminomethyl)tetrahydrofuran-2-carboxylic acid |
| 06/13/2006 | US7060676 Administering a therapeutically effective amount Trypanosoma cruzi trans-sialidase or a neurotrophic variant; amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, Chagas' disease, peripheral neuropathy, |
| 06/13/2006 | US7060675 Administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 06/13/2006 | US7060673 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same |
| 06/13/2006 | US7060671 Peptides containing N-substituted D-amino acids for preventing β-strand association |
| 06/13/2006 | US7060669 in aqueous two-phase systems by fusing hydrophobin or hydrophobin-like protein to a protein of interest, such as an extracellular protein of Trichoderma, selected from the group consisting of cellulases, hemicellulases and proteases. |
| 06/13/2006 | US7060495 Polypeptide for use in as anticarcinogenic agent |
| 06/13/2006 | US7060493 used for assays for the detection of Nod2 and Nod2 polymorphisms associated with Crohn's disease and ulcerative colitis |
| 06/13/2006 | US7060491 Polynucleotides encoding novel BT toxin receptors from lepidopteran insects |
| 06/13/2006 | US7060490 having an N-terminal domain, a DNA-binding domain and a ligand-binding domain |
| 06/13/2006 | US7060481 Comprises peptide for diagnosing and treating inflammatory, tumor, arthritic and nervous system disorders |
| 06/13/2006 | US7060480 MRE11 orthologue and uses thereof |
| 06/13/2006 | US7060479 Full-length human cDNAs encoding potentially secreted proteins |
| 06/13/2006 | US7060475 Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in methylophilus methylotrophus |
| 06/13/2006 | US7060474 Carbohydrate oxidase and use thereof in baking |
| 06/13/2006 | US7060464 Peptides conferring environmental stress resistance and fusion proteins including said peptides |
| 06/13/2006 | US7060463 DNA molecules encoding Macaca mulatta androgen receptor |
| 06/13/2006 | US7060462 Agrobacterium tumefaciens outer membrane protein; |
| 06/13/2006 | US7060461 Genetic engineering; fusion protein |
| 06/13/2006 | US7060458 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 06/13/2006 | US7060449 Method of preparing GALR2 receptors composition |
| 06/13/2006 | US7060442 Comprises muropeptides which activate nuclear factor kappa B; drug screening; inflammatory bowel diseases |
| 06/13/2006 | US7060429 Treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms |
| 06/13/2006 | US7060284 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 06/13/2006 | US7060283 capable of binding with antibody in a specimen from an individual with Epstein-Barr virus (EBV)-associated disease; diagnosis and treatment of EBV-associated disease |
| 06/13/2006 | US7060282 Equine herpesvirus (EHV) mutants are stable and have reduced virulence, which makes them very suitable for use in a live vaccine; vaccines comprising EHV mutants, DNA sequences and vectors harbouring a mutated EHV sequence, host cells transfected with the DNA |
| 06/13/2006 | US7060281 Groups of barrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
| 06/13/2006 | US7060280 Immunization against flavivirus |
| 06/13/2006 | US7060279 Compositions and methods for dendritic cell-based immunotherapy |
| 06/13/2006 | US7060278 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 06/13/2006 | US7060277 For the treatment or prophylaxis of toxic shock; peptides homologous to the amino acid sequence of a fragment of Staphylococcal aureus enterotoxin B (SEB); kits |
| 06/13/2006 | US7060276 Plasmodium falciparum AMA-1 protein and uses thereof |